| Unknown | A Study Evaluating MM-310 in Patients With Solid Tumors Solid Tumors, Urothelial Carcinoma, Gastric Carcinoma | Phase 1 | 2017-02-22 |
| Withdrawn | Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer Colorectal Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Terminated | Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib Colorectal Cancer, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck | Phase 1 | 2015-08-01 |
| Completed | A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2015-05-01 |
| Terminated | MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advan Breast Cancer, HER2 Positive Breast Cancer | Phase 2 / Phase 3 | 2014-07-01 |
| Terminated | A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer | Phase 2 | 2013-01-01 |
| Completed | A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors Hepatocellular Carcinoma | Phase 1 | 2012-11-01 |
| Completed | Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment Advanced Solid Tumors, Colorectal Cancer, Squamous Cell Head and Neck Cancer | Phase 1 | 2012-01-01 |
| Completed | Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 3 | 2011-11-01 |
| Completed | A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | Phase 2 | 2011-10-01 |
| Completed | Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumor Solid Tumors | Phase 1 | 2011-10-01 |
| Completed | A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers Colorectal Cancer, Squamous Cell Head and Neck Cancer, Non-small Cell Lung Cancer | Phase 1 | 2011-10-01 |
| Completed | A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer Patients | Phase 2 | 2011-08-01 |
| Unknown | Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer Breast Cancer | Phase 1 | 2011-03-01 |
| Completed | A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer HER-2 Gene Amplification | Phase 1 | 2011-01-01 |
| Completed | A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,, Primary Peritoneal Cancer or Endometrial Cancer, Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer | Phase 1 | 2010-10-01 |
| Completed | Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor P Her2 Negative Breast Cancer Patients | Phase 2 | 2010-06-01 |
| Completed | MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cance Breast Neoplasms | Phase 1 | 2010-04-01 |
| Completed | A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2010-02-01 |
| Completed | A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers Her2 Amplified Solid Tumors, Metastatic Breast Cancer | Phase 1 | 2009-06-01 |
| Completed | Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment Advanced Solid Tumors | Phase 1 | 2008-07-01 |
| Completed | A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthr Rheumatoid Arthritis | Phase 2 | 2007-02-01 |
| Completed | Phase 2 Study of MM-093 to Treat Patients With Uveitis Uveitis | Phase 2 | 2007-02-01 |
| Completed | Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis Psoriasis | Phase 2 | 2005-09-01 |
| Completed | Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) Rheumatoid Arthritis | Phase 2 | 2005-02-01 |